- Home
- Publications
- Publication Search
- Publication Details
Title
Combination Immune Checkpoint Blockade to Reverse HIV Latency
Authors
Keywords
-
Journal
JOURNAL OF IMMUNOLOGY
Volume 204, Issue 5, Pages 1242-1254
Publisher
The American Association of Immunologists
Online
2020-01-28
DOI
10.4049/jimmunol.1901191
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1(PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer
- (2019) Shahla Bari et al. Journal of Oncology
- Safety and Efficacy of Immune Checkpoint Inhibitor Therapy in Patients With HIV Infection and Advanced-Stage Cancer
- (2019) Michael R. Cook et al. JAMA Oncology
- PD-1 blockade potentiates HIV latency reversal ex vivo in CD4+ T cells from ART-suppressed individuals
- (2019) Rémi Fromentin et al. Nature Communications
- Histone deacetylase inhibitors induce complex host responses that contribute to differential potencies of these compounds in HIV reactivation
- (2019) Nadejda Beliakova-Bethell et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer—A Phase 1 Study
- (2019) Thomas S. Uldrick et al. JAMA Oncology
- Immunotherapy for cancer in people living with HIV
- (2019) Jean-Philippe Spano et al. AIDS
- Between a shock and a hard place: challenges and developments in HIV latency reversal
- (2019) Jennifer M Zerbato et al. Current Opinion in Virology
- Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latency
- (2018) Vanessa A. Evans et al. AIDS
- Inconsistent HIV reservoir dynamics and immune responses following anti-PD-1 therapy in cancer patients with HIV infection
- (2018) E P Scully et al. ANNALS OF ONCOLOGY
- Getting the “Kill” into “Shock and Kill”: Strategies to Eliminate Latent HIV
- (2018) Youry Kim et al. Cell Host & Microbe
- Myeloid Dendritic Cells Induce HIV Latency in Proliferating CD4+T Cells
- (2018) Nitasha A. Kumar et al. JOURNAL OF IMMUNOLOGY
- Nivolumab Treatment for Cancers in the HIV-infected Population
- (2018) Elaine Chang et al. JOURNAL OF IMMUNOTHERAPY
- HIV latency in isolated patient CD4 + T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing
- (2018) Steven A. Yukl et al. Science Translational Medicine
- Concurrent, but not sequential, PD-1 blockade with a DNA vaccine elicits anti-tumor responses in patients with metastatic, castration-resistant prostate cancer
- (2018) Douglas G. McNeel et al. Oncotarget
- Treatment of HIV-Infected Individuals with the Histone Deacetylase Inhibitor Panobinostat Results in Increased Numbers of Regulatory T Cells and Limits Ex Vivo Lipopolysaccharide-Induced Inflammatory Responses
- (2018) Christel Rothe Brinkmann et al. mSphere
- Complete response to ipilimumab and nivolumab therapy in a patient with extensive extrapulmonary high-grade small cell carcinoma of the pancreas and HIV infection
- (2018) Muhammad Husnain et al. Journal for ImmunoTherapy of Cancer
- In vivo Administration of histone deacetylase inhibitors does not impair natural killer cell function in HIV+ individuals
- (2018) Carolina Garrido et al. AIDS
- CTLA-4 + PD-1 − Memory CD4 + T Cells Critically Contribute to Viral Persistence in Antiretroviral Therapy-Suppressed, SIV-Infected Rhesus Macaques
- (2017) Colleen S. McGary et al. IMMUNITY
- Proliferation of latently infected CD4+T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics
- (2017) Nina N. Hosmane et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Defining total-body AIDS-virus burden with implications for curative strategies
- (2017) Jacob D Estes et al. NATURE MEDICINE
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ex vivo activation of CD4+ T-cells from donors on suppressive ART can lead to sustained production of infectious HIV-1 from a subset of infected cells
- (2017) John K. Bui et al. PLoS Pathogens
- In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication
- (2017) Matthew D. Marsden et al. PLoS Pathogens
- The Molecular Basis for Human Immunodeficiency Virus Latency
- (2017) Uri Mbonye et al. Annual Review of Virology
- Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy
- (2016) Carolina Gutiérrez et al. AIDS
- Immune checkpoint inhibitor combinations in solid tumors: opportunities and challenges
- (2016) Chrisann Kyi et al. Immunotherapy
- International AIDS Society global scientific strategy: towards an HIV cure 2016
- (2016) Steven G Deeks et al. NATURE MEDICINE
- PD-1+ and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals
- (2016) Riddhima Banga et al. NATURE MEDICINE
- Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA
- (2016) Julio C. C. Lorenzi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function
- (2016) G. Clutton et al. Scientific Reports
- Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function
- (2016) Matthew Pace et al. PLoS Pathogens
- A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes
- (2016) R. Brad Jones et al. PLoS Pathogens
- Effect of ipilimumab on the HIV reservoir in an HIV-infected individual with metastatic melanoma
- (2015) Fiona Wightman et al. AIDS
- HIV therapeutic vaccines: moving towards a functional cure
- (2015) Geetha H Mylvaganam et al. CURRENT OPINION IN IMMUNOLOGY
- The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells
- (2015) Nitasha A. Kumar et al. Retrovirology
- The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
- (2015) Ole S. Søgaard et al. PLoS Pathogens
- The immune checkpoint inhibitors: where are we now?
- (2014) Rachel M. Webster NATURE REVIEWS DRUG DISCOVERY
- Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy
- (2014) Julian H. Elliott et al. PLoS Pathogens
- Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
- (2014) Thomas A Rasmussen et al. Lancet HIV
- Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure
- (2013) Ya-Chi Ho et al. CELL
- An In-Depth Comparison of Latent HIV-1 Reactivation in Multiple Cell Model Systems and Resting CD4+ T Cells from Aviremic Patients
- (2013) Celsa A. Spina et al. PLoS Pathogens
- Myeloid Dendritic Cells Induce HIV-1 Latency in Non-proliferating CD4+ T Cells
- (2013) Vanessa A. Evans et al. PLoS Pathogens
- Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
- (2012) N. M. Archin et al. NATURE
- Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells
- (2011) Suha Saleh et al. Retrovirology
- Clarifying the Mechanism of Superantigen Toxicity
- (2011) John D. Fraser PLOS BIOLOGY
- Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton
- (2010) P. U. Cameron et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PD-1 and CTLA-4 Inhibitory Cosignaling Pathways in HIV Infection and the Potential for Therapeutic Intervention
- (2009) Daniel E. Kaufmann et al. JOURNAL OF IMMUNOLOGY
- HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
- (2009) Nicolas Chomont et al. NATURE MEDICINE
- Selective Transmission of R5 HIV-1 over X4 HIV-1 at the Dendritic Cell–T Cell Infectious Synapse Is Determined by the T Cell Activation State
- (2009) Takuya Yamamoto et al. PLoS Pathogens
- Analysis of superantigenic toxin Vβ T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock
- (2008) T. Ferry et al. CLINICAL MICROBIOLOGY AND INFECTION
- Persistence of HIV in Gut‐Associated Lymphoid Tissue despite Long‐Term Antiretroviral Therapy
- (2008) Tae‐Wook Chun et al. JOURNAL OF INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now